With Lyonbiopôle, a world competitive cluster dedicated to the fight against infectious diseases, Lyon, together with Grenoble, is a world center of excellence in diagnostics and vaccines. Designed as a factory for developing multi-partner R&D projects, Lyonbiopôle is an interface between the industrial and academic research spheres, helping to bring them closer together.
Lyonbiopôle is :
The development of a healthcare shield for comprehensive protection against infectious diseases, from diagnostics up to treatment
A combination of distinctive yet complementary expertise:
Sanofi Pasteur, #1 worldwide in human vaccines
Merial, #1 worldwide in veterinary products
bioMérieux, #1 worldwide in bacteriological diagnostics
BD, world leader in the medical and diagnostics fields.
Lyonbiopôle relies on several of the regions assets, in particular:
A number of international organizations and major technical platforms, such as the WHO Communicable Disease Surveillance and Response Center (CSR), the Virology and Immunology Research Center (CERVI), the Jean Mérieux Biosafety Level 4 Laboratory (one of only two BSL4 in Europe) and others,